0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
China Anti-inflammatory Therapeutics Market Report & Forecast 2021-2027
Published Date: October 2021
|
Report Code: QYRE-Auto-4J2573
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
China Anti inflammatory Therapeutics Market Report Forecast 2021 2027

China Anti-inflammatory Therapeutics Market Report & Forecast 2021-2027

Code: QYRE-Auto-4J2573
Report
October 2021
Pages:90
QYResearch
Description
Table of Content
Tables & Figures
China Anti-inflammatory Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ Millions)
China Anti-inflammatory Therapeutics Market Segment Percentages, By Type, 2020 (%)
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Others
China Anti-inflammatory Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ Millions)
China Anti-inflammatory Therapeutics Market Segment Percentages, By Application, 2020 (%)
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-inflammatory Therapeutics revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Anti-inflammatory Therapeutics revenues share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA
1 Introduction to Research & Analysis Reports
1.1 Anti-inflammatory Therapeutics Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Anti-inflammatory Therapeutics Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Anti-inflammatory Therapeutics Overall Market Size
2.1 China Anti-inflammatory Therapeutics Market Size: 2021 VS 2027
2.2 China Anti-inflammatory Therapeutics Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-inflammatory Therapeutics Players in China Market
3.2 Top China Anti-inflammatory Therapeutics Companies Ranked by Revenue
3.3 China Anti-inflammatory Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Anti-inflammatory Therapeutics Companies in China Market, by Revenue in 2020
3.5 Companies Anti-inflammatory Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-inflammatory Therapeutics Players in China Market
3.6.1 List of Tier 1 Anti-inflammatory Therapeutics Companies in China
3.6.2 List of Tier 2 and Tier 3 Anti-inflammatory Therapeutics Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Anti-inflammatory Therapeutics Market Size Markets, 2021 & 2027
4.1.2 Anti-inflammatory Biologics
4.1.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
4.1.4 Corticosteroids
4.1.5 Others
4.2 By Type - China Anti-inflammatory Therapeutics Revenue & Forecasts
4.2.1 By Type - China Anti-inflammatory Therapeutics Revenue, 2016-2021
4.2.2 By Type - China Anti-inflammatory Therapeutics Revenue, 2022-2027
4.2.3 By Type - China Anti-inflammatory Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Anti-inflammatory Therapeutics Market Size, 2021 & 2027
5.1.2 Arthritis
5.1.3 Respiratory Diseases
5.1.4 Dermatology
5.1.5 Gastroenterology
5.1.6 Others
5.2 By Application - China Anti-inflammatory Therapeutics Revenue & Forecasts
5.2.1 By Application - China Anti-inflammatory Therapeutics Revenue, 2016-2021
5.2.2 By Application - China Anti-inflammatory Therapeutics Revenue, 2022-2027
5.2.3 By Application - China Anti-inflammatory Therapeutics Revenue Market Share, 2016-2027
6 Anti-inflammatory Therapeutics Companies Profiles
6.1 AbbVie
6.1.1 AbbVie Company Details
6.1.2 AbbVie Business Overview
6.1.3 AbbVie Anti-inflammatory Therapeutics Introduction
6.1.4 AbbVie Anti-inflammatory Therapeutics Revenue in China Market (2016-2021)
6.1.5 AbbVie Recent Developments
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Company Details
6.2.2 Johnson & Johnson Business Overview
6.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Introduction
6.2.4 Johnson & Johnson Anti-inflammatory Therapeutics Revenue in China Market (2016-2021)
6.2.5 Johnson & Johnson Recent Developments
6.3 Amgen Inc
6.3.1 Amgen Inc Company Details
6.3.2 Amgen Inc Business Overview
6.3.3 Amgen Inc Anti-inflammatory Therapeutics Introduction
6.3.4 Amgen Inc Anti-inflammatory Therapeutics Revenue in China Market (2016-2021)
6.3.5 Amgen Inc Recent Developments
6.4 AstraZeneca PLC
6.4.1 AstraZeneca PLC Company Details
6.4.2 AstraZeneca PLC Business Overview
6.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Introduction
6.4.4 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue in China Market (2016-2021)
6.4.5 AstraZeneca PLC Recent Developments
6.5 Pfizer, Inc
6.5.1 Pfizer, Inc Company Details
6.5.2 Pfizer, Inc Business Overview
6.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Introduction
6.5.4 Pfizer, Inc Anti-inflammatory Therapeutics Revenue in China Market (2016-2021)
6.5.5 Pfizer, Inc Recent Developments
6.6 Novartis
6.6.1 Novartis Company Details
6.6.2 Novartis Business Overview
6.6.3 Novartis Anti-inflammatory Therapeutics Introduction
6.6.4 Novartis Anti-inflammatory Therapeutics Revenue in China Market (2016-2021)
6.6.5 Novartis Recent Developments
6.7 Roche
6.7.1 Roche Company Details
6.7.2 Roche Business Overview
6.7.3 Roche Anti-inflammatory Therapeutics Introduction
6.7.4 Roche Anti-inflammatory Therapeutics Revenue in China Market (2016-2021)
6.7.5 Roche Recent Developments
6.8 Merck
6.8.1 Merck Company Details
6.8.2 Merck Business Overview
6.8.3 Merck Anti-inflammatory Therapeutics Introduction
6.8.4 Merck Anti-inflammatory Therapeutics Revenue in China Market (2016-2021)
6.8.5 Merck Recent Developments
6.9 Sanofi
6.9.1 Sanofi Company Details
6.9.2 Sanofi Business Overview
6.9.3 Sanofi Anti-inflammatory Therapeutics Introduction
6.9.4 Sanofi Anti-inflammatory Therapeutics Revenue in China Market (2016-2021)
6.9.5 Sanofi Recent Developments
6.10 GlaxoSmithKline
6.10.1 GlaxoSmithKline Company Details
6.10.2 GlaxoSmithKline Business Overview
6.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Introduction
6.10.4 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue in China Market (2016-2021)
6.10.5 GlaxoSmithKline Recent Developments
6.11 Sun Pharmaceutical Industries Ltd
6.11.1 Sun Pharmaceutical Industries Ltd Company Details
6.11.2 Sun Pharmaceutical Industries Ltd Business Overview
6.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Introduction
6.11.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue in China Market (2016-2021)
6.11.5 Sun Pharmaceutical Industries Ltd Recent Developments
6.12 TEVA
6.12.1 TEVA Company Details
6.12.2 TEVA Business Overview
6.12.3 TEVA Anti-inflammatory Therapeutics Introduction
6.12.4 TEVA Anti-inflammatory Therapeutics Revenue in China Market (2016-2021)
6.12.5 TEVA Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
    Table 1. Anti-inflammatory Therapeutics Market Opportunities & Trends in China Market
    Table 2. Anti-inflammatory Therapeutics Market Drivers in China Market
    Table 3. Anti-inflammatory Therapeutics Market Restraints in China Market
    Table 4. Key Players of Anti-inflammatory Therapeutics in China Market
    Table 5. Top Anti-inflammatory Therapeutics Players in China Market, Ranking by Revenue (2019)
    Table 6. China Anti-inflammatory Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
    Table 7. China Anti-inflammatory Therapeutics Revenue Share by Companies, 2016-2021
    Table 8. Companies Anti-inflammatory Therapeutics Product Type
    Table 9. List of Tier 1 Anti-inflammatory Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Tier 2 and Tier 3 Anti-inflammatory Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. By Type – China Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2021 & 2027
    Table 12. By Type - China Anti-inflammatory Therapeutics Revenue (US$, Mn), 2016-2021
    Table 13. By Type - China Anti-inflammatory Therapeutics Revenue (US$, Mn), 2022-2027
    Table 14. By Application – China Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2021 VS 2027
    Table 15. By Application - China Anti-inflammatory Therapeutics Revenue (US$, Mn), 2016-2021
    Table 16. By Application - China Anti-inflammatory Therapeutics Revenue (US$, Mn), 2022-2027
    Table 17. AbbVie Company Details
    Table 18. AbbVie Business Overview
    Table 19. AbbVie Anti-inflammatory Therapeutics Product
    Table 20. AbbVie Anti-inflammatory Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
    Table 21. AbbVie Recent Developments
    Table 22. Johnson & Johnson Company Details
    Table 23. Johnson & Johnson Business Overview
    Table 24. Johnson & Johnson Anti-inflammatory Therapeutics Product
    Table 25. Johnson & Johnson Anti-inflammatory Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
    Table 26. Johnson & Johnson Recent Developments
    Table 27. Amgen Inc Company Details
    Table 28. Amgen Inc Business Overview
    Table 29. Amgen Inc Anti-inflammatory Therapeutics Product
    Table 30. Amgen Inc Anti-inflammatory Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
    Table 31. Amgen Inc Recent Developments
    Table 32. AstraZeneca PLC Company Details
    Table 33. AstraZeneca PLC Business Overview
    Table 34. AstraZeneca PLC Anti-inflammatory Therapeutics Product
    Table 35. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
    Table 36. AstraZeneca PLC Recent Developments
    Table 37. Pfizer, Inc Company Details
    Table 38. Pfizer, Inc Business Overview
    Table 39. Pfizer, Inc Anti-inflammatory Therapeutics Product
    Table 40. Pfizer, Inc Anti-inflammatory Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
    Table 41. Pfizer, Inc Recent Developments
    Table 42. Novartis Company Details
    Table 43. Novartis Business Overview
    Table 44. Novartis Anti-inflammatory Therapeutics Product
    Table 45. Novartis Anti-inflammatory Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
    Table 46. Novartis Recent Developments
    Table 47. Roche Company Details
    Table 48. Roche Business Overview
    Table 49. Roche Anti-inflammatory Therapeutics Product
    Table 50. Roche Anti-inflammatory Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
    Table 51. Roche Recent Developments
    Table 52. Merck Company Details
    Table 53. Merck Business Overview
    Table 54. Merck Anti-inflammatory Therapeutics Product
    Table 55. Merck Anti-inflammatory Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
    Table 56. Merck Recent Developments
    Table 57. Sanofi Company Details
    Table 58. Sanofi Business Overview
    Table 59. Sanofi Anti-inflammatory Therapeutics Product
    Table 60. Sanofi Anti-inflammatory Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
    Table 61. Sanofi Recent Developments
    Table 62. GlaxoSmithKline Company Details
    Table 63. GlaxoSmithKline Business Overview
    Table 64. GlaxoSmithKline Anti-inflammatory Therapeutics Product
    Table 65. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
    Table 66. GlaxoSmithKline Recent Developments
    Table 67. Sun Pharmaceutical Industries Ltd Company Details
    Table 68. Sun Pharmaceutical Industries Ltd Business Overview
    Table 69. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product
    Table 70. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
    Table 71. Sun Pharmaceutical Industries Ltd Recent Developments
    Table 72. TEVA Company Details
    Table 73. TEVA Business Overview
    Table 74. TEVA Anti-inflammatory Therapeutics Product
    Table 75. TEVA Anti-inflammatory Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
    Table 76. TEVA Recent Developments
List of Figures
    Figure 1. Anti-inflammatory Therapeutics Segment by Type
    Figure 2. Anti-inflammatory Therapeutics Segment by Application
    Figure 3. China Anti-inflammatory Therapeutics Market Overview: 2020
    Figure 4. China Anti-inflammatory Therapeutics Market Size: 2021 VS 2027 (US$, Mn)
    Figure 5. China Anti-inflammatory Therapeutics Revenue, 2016-2027 (US$, Mn)
    Figure 6. The Top 3 and 5 Players Market Share by Anti-inflammatory Therapeutics Revenue in 2020
    Figure 7. By Type - China Anti-inflammatory Therapeutics Revenue Market Share, 2016-2027
    Figure 8. By Application - China Anti-inflammatory Therapeutics Revenue Market Share, 2016-2027
    Figure 9. AbbVie Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 10. Johnson & Johnson Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 11. Amgen Inc Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 12. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 13. Pfizer, Inc Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 14. Novartis Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 15. Roche Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 16. Merck Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 17. Sanofi Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 18. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 19. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 20. TEVA Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3400

This license allows only one user(purchaser of the report) to access the PDF.
Electronic (PDF)

$5100

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Microcarrier Bioreactor Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4O8609
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Immunohistochemistry Reagent Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-25I8231
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global RNA Analysis & Transcriptomic Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-2M4266
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global PCR Tubes And PCR Plates Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-38E8328
Wed Apr 17 00:00:00 UTC 2024

Add to Cart